SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.41 |
| Enterprise Value ($M) | 2.41 |
| Book Value ($M) | 0.00 |
| Book Value / Share | 0.00 |
| Price / Book | n/a |
| NCAV ($M) | 0.00 |
| NCAV / Share | 0.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | n/a |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.00 |
| Assets | 0.00 |
| Liabilities | 0.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Streeterville Capital LLC | 0.00 | -100.00 | |
| 13G/A | Forsakringsaktiebolaget Avanza Pension | 1.00 | 46.68 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 14,819 | 116,869 | 12.68 | |
| 22,238 | 83,237 | 26.72 | |
| 8,876 | 39,577 | 22.43 | |
| 12,177 | 44,094 | 27.62 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SONN – Sonnet BioTherapeutics Holdings, Inc. | SPRB – Spruce Biosciences, Inc. |
| SRZN – Surrozen, Inc. | SXTP – 60 Degrees Pharmaceuticals, Inc. |
| SYBX – Synlogic, Inc. |
Financial data and stock pages provided by
Fintel.io